AGF MANAGEMENT LTD - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
AGF MANAGEMENT LTD ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q2 2023$1,996,290
-46.9%
4,100,000
-56.8%
0.01%
-46.2%
Q1 2023$3,762,950
-33.6%
9,500,000
-9.5%
0.03%
-36.6%
Q4 2022$5,670,00010,500,0000.04%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
Context Capital Management, LLC 18,764$9,907,0000.77%
Pentwater Capital Management LP 46,411,000$24,770,0000.27%
WHITEBOX ADVISORS LLC 22,500,000$11,756,0000.24%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$10,993,0000.23%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 17,590,000$9,286,0000.20%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$12,540,0000.18%
BlueCrest Capital Management Ltd 7,000,000$3,705,0000.12%
DCF Advisers, LLC 400,000$211,0000.09%
Walleye Capital LLC 5,000$2,638,0000.08%
INGALLS & SNYDER LLC 883,000$461,0000.02%
View complete list of ESPERION THERAPEUTICS INC NE shareholders